Connect: New growth areas and a 6% dividend yield (BUY) | M.P. Evans: Four reasons to Buy M.P. Evans (BUY) | The Joy of Techs: finnCap tech Quarterly – analyst interview | PPHE*: Strong demand, rising prices and an expanding portfolio (CORP)| Gemfields: Q1 operating results (BUY)| Akers Biosciences*: PIFA Heparin/PF4 Rapid Assay approved by CFDA (CORP)| Wentworth Resources: Production and payment update (BUY)| Xaar: IMS (HOLD)| In
.png)
